Start › Rak piersi › New Jersey
Badania kliniczne dla Rak piersi w stanie New Jersey
93 badań dla Rak piersi szuka uczestników w ośrodkach w stanie New Jersey.
Miasta w stanie New Jersey
- Edison68 badań
- Newark18 badań
- Clifton12 badań
- Elizabeth10 badań
- Trenton10 badań
- Camden8 badań
- Paterson7 badań
- Brick6 badań
- Toms River4 badań
- Jersey City3 badań
Oficjalny tekst badania (angielski)
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
- MD Anderson Cancer Center At Cooper, Camden
- Summit Health, Florham Park
- The Valley Hospital, Ridgewood
RekrutacjaFaza 3
Wiek od 18 do 100 · Obie płcie · Zaktualizowano 2 paź 2026 · NCT05827081A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Approach (Drug Therapy) in People With Breast Cancer
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
RekrutacjaFaza 2
Wiek 18 i więcej · Obie płcie · Zaktualizowano 2 paź 2026 · NCT05534438Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Englewood Hospital and Medical Center, Englewood
- Hackettstown Medical Center, Hackettstown
- Morristown Medical Center, Morristown
- i 6 więcej
RekrutacjaBadanie obserwacyjneZapraszamy zdrowych ochotników
Wiek od 40 do 75 · Obie płcie · Zaktualizowano 2 paź 2026 · NCT05334069A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
- Astera Cancer Care (Formerly Regional Cancer Care Associates), East Brunswick
- Medical Oncology Hematology Associates, Newark
RekrutacjaFaza 2
Wiek 18 i więcej · Obie płcie · Zaktualizowano 1 paź 2026 · NCT07102381A Study of a One-Time Counseling Session to Help Reduce Depression, Anxiety, and Distress in People With Cancer
- Memorial Sloan Kettering Basking Ridge (Consent Only), Basking Ridge
- Memorial Sloan Kettering Monmouth (Consent Only), Middletown
- Memorial Sloan Kettering Bergen (Consent Only), Montvale
Rekrutacja
Wiek 18 i więcej · Obie płcie · Zaktualizowano 30 wrz 2026 · NCT07218250A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
- Research Site, New Brunswick
RekrutacjaFaza 1
Wiek 18 i więcej · Obie płcie · Zaktualizowano 29 wrz 2026 · NCT05877599A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
- John Theurer Cancer Center at Hackensack University Medical Center ( Site 0001), Hackensack
- Rutgers Cancer Institute of New Jersey ( Site 0033), New Brunswick
RekrutacjaFaza 3
Wiek 18 i więcej · Obie płcie · Zaktualizowano 28 wrz 2026 · NCT07060807Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy
- Cooper Hospital Univ Med Ctr, MD Anderson at Cooper Voorhees, Voorhees Township
Rekrutacja
Wiek 30 i więcej · Kobiety · Zaktualizowano 25 wrz 2026 · NCT02945579A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
- Hackensack Univ Medical Center (HUMC) ( Site 0007), Hackensack
- Rutgers Cancer Institute of New Jersey ( Site 0076), New Brunswick
RekrutacjaFaza 3
Wiek 18 i więcej · Obie płcie · Zaktualizowano 25 wrz 2026 · NCT06966700The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
- Englewood Hospital, Englewood
- Capital Health Medical Center - Hopewell, Pennington
- Penn Medicine - Princeton Health, Plainsboro
RekrutacjaFaza 3
Wiek 60 i więcej · Obie płcie · Zaktualizowano 25 wrz 2026 · NCT06377852A Study of Language Interpretation Solutions for People With Breast Cancer
- Memorial Sloan Kettering Basking Ridge (Consent Only), Basking Ridge
- Memorial Sloan Kettering Monmouth (Consent Only), Middletown
- Memorial Sloan Kettering Bergen (Consent Only), Montvale
Rekrutacja
Wiek 18 i więcej · Obie płcie · Zaktualizowano 25 wrz 2026 · NCT06721065A Study of an Alternative Treatment Approach (Preoperative Radiotherapy, Then Mastectomy, Then Immediate Reconstruction Surgery) in People With T4 Breast Cancer
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
RekrutacjaFaza 1
Wiek 18 i więcej · Kobiety · Zaktualizowano 24 wrz 2026 · NCT05412225A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack
RekrutacjaFaza 1/2
Wiek 18 i więcej · Obie płcie · Zaktualizowano 23 wrz 2026 · NCT06618287Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
- Cooper Health, Camden
- Rutgers, New Brunswick
Rekrutacja
Wiek 18 i więcej · Obie płcie · Zaktualizowano 23 wrz 2026 · NCT07214532A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
- Jefferson Health - Cherry Hill, Cherry Hill
- Sidney Kimmel Cancer Center - Washington Township, Sewell
- Atlantic Health System Overlook Medical Center, Summit
RekrutacjaFaza 3
Wiek 18 i więcej · Obie płcie · Zaktualizowano 22 wrz 2026 · NCT07174336Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer
- Memorial Sloan Kettering Basking Ridge, Basking Ridge
- Memorial Sloan Kettering Monmouth, Middletown
- Memorial Sloan Kettering Bergen, Montvale
RekrutacjaFaza 2
Wiek 45 i więcej · Kobiety · Zaktualizowano 21 wrz 2026 · NCT04084730ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
- Summit Medical Group PA, Florham Park
- Rutgers Cancer Institute of NJ (Rutgers, The State University of New Jersey), Livingston
- Rutgers Cancer Institute of NJ (Rutgers, The State University of New Jersey), Long Branch
- i 4 więcej
RekrutacjaFaza 3
Wiek 18 i więcej · Obie płcie · Zaktualizowano 17 wrz 2026 · NCT07173751A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
- Memorial Sloan Kettering Cancer Center Basking Ridge, Basking Ridge
- Summit Medical Group, Florham Park
- Memorial Sloan Kettering Cancer Center Monmouth, Middletown
- i 1 więcej
RekrutacjaFaza 1/2
Wiek 18 i więcej · Obie płcie · Zaktualizowano 17 wrz 2026 · NCT06827236A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
- MD Anderson Cancer Center at Cooper, Camden
- Summit Medical Group, Florham Park
- John Theurer Ctr-Hackensack UMC, Hackensack
- i 1 więcej
RekrutacjaFaza 3
Wiek 18 i więcej · Obie płcie · Zaktualizowano 15 wrz 2026 · NCT06492616A Study of Pembrolizumab and Ablation (Cryoablation or Histotripsy) in People With Breast Cancer
- Memorial Sloan Kettering Cancer Center at Basking Ridge (Limited Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (Limited protocol activities), Middletown
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
RekrutacjaFaza 1
Wiek 18 i więcej · Obie płcie · Zaktualizowano 14 wrz 2026 · NCT06246968A Study of Multiparametric MRI and pHLIP® ICG in Breast Cancer Imaging During Surgery
- Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale
RekrutacjaFaza 1/2
Wiek 18 i więcej · Kobiety · Zaktualizowano 11 wrz 2026 · NCT05130801Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
- START - New Jersey, East Brunswick
RekrutacjaFaza 1
Wiek 18 i więcej · Obie płcie · Zaktualizowano 10 wrz 2026 · NCT06293898A Phase 1/1b Study of IAM1363 in HER2 Cancers
- Rutgers Cancer Institute, New Brunswick
RekrutacjaFaza 1
Wiek 18 i więcej · Obie płcie · Zaktualizowano 9 wrz 2026 · NCT06253871A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge
- Hackensack Meridian Health, Hackensack
- Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown
- i 1 więcej
RekrutacjaFaza 2
Wiek 18 i więcej · Obie płcie · Zaktualizowano 9 wrz 2026 · NCT05570253A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
- Rutgers Cancer Institute of New Jersey, New Brunswick
RekrutacjaFaza 1/2
Wiek 18 i więcej · Obie płcie · Zaktualizowano 8 wrz 2026 · NCT07100106To Study the Effect of Inavolisib in Combination With Fulvestrant in Participants With Breast Cancer
- Astera Cancer Care East Brunswick, East Brunswick
RekrutacjaFaza 2
Wiek 18 i więcej · Obie płcie · Zaktualizowano 4 wrz 2026 · NCT07368998Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack
- Rutgers Cancer Institute, New Brunswick
RekrutacjaFaza 3
Wiek 18 i więcej · Obie płcie · Zaktualizowano 3 wrz 2026 · NCT06982521Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies
- Summit Medical Group, Florham Park
RekrutacjaBadanie obserwacyjne
Wiek od 18 do 99 · Obie płcie · Zaktualizowano 3 wrz 2026 · NCT07211178A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
- Astera Cancer Care East Brunswick, East Brunswick
- Summit Medical Group, Florham Park
RekrutacjaFaza 3
Wiek 18 i więcej · Obie płcie · Zaktualizowano 3 wrz 2026 · NCT06790693Observational Study of Bone Complications in People With Post-menopausal Breast Cancer Who Have Stopped Treatment With Denosumab and Aromatase Inhibitors
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
RekrutacjaBadanie obserwacyjne
Wiek 18 i więcej · Kobiety · Zaktualizowano 3 wrz 2026 · NCT05590949A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack
RekrutacjaFaza 1/2
Wiek 18 i więcej · Obie płcie · Zaktualizowano 2 wrz 2026 · NCT07287995Shortening Adjuvant Photon and Proton Irradiation (SAPPHIRe-II): A 4 Cohort, Randomized, Phase II Multi-center Trial Evaluating Shorter Schedules of Adjuvant Regional Nodal Irradiation Among Women and Men With Node-positive and High-risk Node-negative Invasive Breast Cancer
- Cooper Hospital University Medical Center, Voorhees Township
RekrutacjaFaza 2
Wiek 18 i więcej · Obie płcie · Zaktualizowano 2 wrz 2026 · NCT07076485A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
- Memorial Sloan Kettering Bergen (Limited protocol activities), Montvale
Rekrutacja
Wiek 18 i więcej · Obie płcie · Zaktualizowano 2 wrz 2026 · NCT05837767Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
- Cooper Hospital University Medical Center, Camden
- Jefferson Cherry Hill Hospital, Cherry Hill
- Trinitas Hospital and Comprehensive Cancer Center - Williamson Street Campus, Elizabeth
- i 21 więcej
RekrutacjaFaza 3
Wiek od 18 do 60 · Kobiety · Zaktualizowano 2 wrz 2026 · NCT05879926Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
- Hunterdon Medical Center, Flemington
RekrutacjaFaza 3
Wiek 18 i więcej · Obie płcie · Zaktualizowano 2 wrz 2026 · NCT06072612Study of Aerobic Training for People Receiving Treatment for Breast Cancer
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
- Memorial Sloan Kettering Bergen (Limited protocol activities), Montvale
RekrutacjaFaza 2
Wiek 18 i więcej · Kobiety · Zaktualizowano 27 sie 2026 · NCT05716893A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
- START New Jersey, LLC, East Brunswick
RekrutacjaFaza 1
Wiek 18 i więcej · Obie płcie · Zaktualizowano 26 sie 2026 · NCT07383506KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer
- Rutgers Cancer Institute, New Brunswick
- RWJBarnabas Health - Robert Wood Johnson University Hospital, New Brunswick
RekrutacjaFaza 1
Wiek 18 i więcej · Obie płcie · Zaktualizowano 25 sie 2026 · NCT05483491A Phase 1 Study of LNCB74 in Advanced Solid Tumors
- John Theurer Cancer Ctr at Hackensack Univ. Med Ctr., Hackensack
RekrutacjaFaza 1
Wiek 18 i więcej · Obie płcie · Zaktualizowano 21 sie 2026 · NCT06774963HERizon-Breast: A ctDNA-Guided Adaptive Study of Sequential Anti-HER2 Therapies and CNS Prophylaxis to Induce Long-Term Remission
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge
- Memorial Sloan Kettering at Monmouth (Limited Protocol Activities), Middletown
- Memorial Sloan Kettering at Bergen (Limited Protocol Activities), Montvale
RekrutacjaFaza 2
Wiek 18 i więcej · Obie płcie · Zaktualizowano 20 sie 2026 · NCT07459673Źródło: ClinicalTrials.gov, dane pobrane 5 paź 2026. Każde badanie ustala własne kryteria kwalifikacji; zespół badawczy decyduje, kto może wziąć udział.